Markets
EW

Sunshine Heart (SSH) in Focus: Stock Moves 7.9% Higher - Tale of the Tape

Sunshine Heart Inc. ( SSH ) was a big mover last session with its shares rising nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading above past one month's volatile price range of $4.19 to $5.25.

This early-stage medical device company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn't been in trend either. Yesterday's sharp climb is encouraging though, so make sure to keep a close watch on this firm in the near future.

Sunshine Heart currently has a Zacks Rank #4 (Sell) while its Earnings ESP is negative.

Investors interested in the Med Instruments industry may consider better-ranked stocks like RTI Surgical Inc. ( RTIX ), Alphatec Holdings, Inc. ( ATEC ) and Edwards Lifesciences Corp. ( EW ). While RTI Surgical and Alphatec Holdings sport a Zacks Rank #1 (Strong Buy), Edwards Lifesciences carries a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

SUNSHINE HEART (SSH): Free Stock Analysis Report

RTI SURGICAL (RTIX): Free Stock Analysis Report

ALPHATEC HLDGS (ATEC): Free Stock Analysis Report

EDWARDS LIFESCI (EW): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

EW ATEC SRGA

Other Topics

Investing Stocks

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More